This preclinical research project seeks to identify phytocannabinoids and full-spectrum extracts with therapeutic potential to treat PTSD using a preclinical disease model in mice. Performing preclinical studies will help identify lead cannabinoid compounds for clinical development. Moreover, they will instruct our clinical researchers on the best way to design their studies.
Research Team: Associate Professor Jonathon Arnold, Dr Anand Gururajan, Professor Iain McGregor (Lambert Initiative, University of Sydney)